New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
No clinically approved therapies are currently available that prevent the onset of photoreceptor death in retinal degeneration. Signaling between retinal neurons is regulatedby the release and uptake of neurotransmitters, wherein GABA is the main inhibitory neurotransmitter. In this work, novel 3‐chloropropiophenone derivatives and the clinical anticonvulsants tiagabine and vigabatrin were tested to modulate GABA signaling and protect against light‐induced retinal degeneration. Abca4 −/− Rdh8 −/− mice, an accelerated model of retinal degeneration, were exposed to intense light after prophylactic injections of one of these compounds. Imaging and functional assessments of the retina indicated that these compounds successfully protected photoreceptor cells from degeneration to maintain a full‐visual‐field response. Furthermore, these compounds demonstrated a strong safety profile in wild‐type mice and did not compromise visual function or damage the retina, despite repeated administration. These results indicate that modulating inhibitory GABA signaling can offer prophylactic protection against light‐induced retinal degeneration.—Schur, R. M., Gao, S., Yu, G., Chen, Y., Maeda, A., Palczewski, K., Lu, Z.‐R. New GABA modulators protect photoreceptor cells from light‐induced degeneration in mouse models. FASEB J. 32, 3289–3300 (2018). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposure of the retina to excessive light (i.e., 10,000 lux for 30–60 min in a photosensitive Abca4 −/− Rdh8 −/− mouse model) causes photoreceptor cell death, retinal inflammation and other degenerative changes [ 63 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [63]
Citations
Cites
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1430 · Cited by 1,239
Mechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,021
Mattapallil, M. J., Wawrousek, E. F., Chan, C.-C., Zhao, H., Roychoudhury, J., Ferguson, T. A., & Caspi, R. R. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9662 · Cited by 678
Wenzel, A., Grimm, C., Samardzija, M., & Remé, C. E. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.08.002 · Cited by 644
Oxidative Damage and Age Related Macular Degeneration
Renganathan, K. (2008) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 566
(1999) · PubMed · Cited by 539
Age-Related Macular Degeneration: Genetics and Biology Coming Together
Fritsche, L. G., Fariss, R. N., Stambolian, D., Abecasis, G. R., Curcio, C. A., & Swaroop, A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025610 · Cited by 534
Diseases Caused by Defects in the Visual Cycle: Retinoids as Potential Therapeutic Agents
Travis, G. H., Golczak, M., Moise, A. R., & Palczewski, K. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105225 · Cited by 419
Self-citationRetinopathy in Mice Induced by Disrupted All-trans-retinal Clearance
Maeda, A., Maeda, T., Golczak, M., & Palczewski, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804505200 · Cited by 300
Self-citationFariss, R. N., Li, Z.-Y., & Milam, A. H. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00401-8 · Cited by 273
Involvement of All-trans-retinal in Acute Light-induced Retinopathy of Mice
Maeda, A., Maeda, T., Golczak, M., Chou, S., Desai, A., Hoppel, C. L., Matsuyama, S., & Palczewski, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900322200 · Cited by 248
Self-citationCharacterization of receptors for glutamate and GABA in retinal neurons
Yang, X.-L. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.04.002 · Cited by 235
Louzada, P. R., Lima, A. C. P., Mendonca‐Silva, D. L., Noël, F., De Mello, F. G., & Ferreira, S. T. (2004) · The FASEB Journal · doi:10.1096/fj.03-0739com · Cited by 234
Cayouette, M., Behn, D., Sendtner, M., Lachapelle, P., & Gravel, C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-22-09282.1998 · Cited by 228
Kohno, H., Chen, Y., Kevany, B. M., Pearlman, E., Miyagi, M., Maeda, T., Palczewski, K., & Maeda, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448712 · Cited by 176
Self-citationYu, D.-Y., Cringle, S., Valter, K., Walsh, N., Lee, D., & Stone, J. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0845 · Cited by 165
Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review
Maguire, M. J., Hemming, K., Wild, J. M., Hutton, J. L., & Marson, A. G. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02772.x · Cited by 159
Abnormalities in Glutamate Metabolism and Excitotoxicity in the Retinal Diseases
Ishikawa, M. (2013) · Scientifica · doi:10.1155/2013/528940 · Cited by 154
Taurine: The comeback of a neutraceutical in the prevention of retinal degenerations
Froger, N., Moutsimilli, L., Cadetti, L., Jammoul, F., Wang, Q., Fan, Y., Gaucher, D., Rosolen, S. G., Neveux, N., Cynober, L., et al. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.03.001 · Cited by 141
Primary amines protect against retinal degeneration in mouse models of retinopathies
Maeda, A., Golczak, M., Chen, Y., Okano, K., Kohno, H., Shiose, S., Ishikawa, K., Harte, W., Palczewska, G., Maeda, T., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.759 · Cited by 135
Self-citationValproic Acid–Mediated Neuroprotection and Regeneration in Injured Retinal Ganglion Cells
Biermann, J., Grieshaber, P., Goebel, U., Martin, G., Thanos, S., Giovanni, S. D., & Lagrèze, W. A. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3903 · Cited by 129
The effect of antiepileptic drugs on visual performance
Hilton, E. J. R., Hosking, S. L., & Betts, T. (2003) · Seizure · doi:10.1016/s1059-1311(03)00082-7 · Cited by 120
Amino acid neurochemistry of the vertebrate retina
Kalloniatis, M., & Tomisich, G. (1999) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(98)00036-6 · Cited by 117
Vigabatrin Visual Toxicity: Evolution and Dose Dependence
Malmgren, K., Ben‐Menachem, E., & Frisén, L. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.28600.x · Cited by 112
Tauroursodeoxycholic Acid Prevents Retinal Degeneration in Transgenic P23H Rats
Fernández-Sánchez, L., Lax, P., Pinilla, I., Martín-Nieto, J., & Cuenca, N. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-7496 · Cited by 103
SAFETY AND EFFECT ON ROD FUNCTION OF ACU-4429, A NOVEL SMALL-MOLECULE VISUAL CYCLE MODULATOR
Kubota, R., Boman, N. L., David, R., Mallikaarjun, S., Patil, S., & Birch, D. (2012) · Retina · doi:10.1097/iae.0b013e318217369e · Cited by 97
Maeda, A., Maeda, T., Golczak, M., Imanishi, Y., Leahy, P. S., Kubota, R., & Palczewski, K. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026823 · Cited by 84
Self-citationSystems pharmacology identifies drug targets for Stargardt disease–associated retinal degeneration
Chen, Y., Palczewska, G., Mustafi, D., Golczak, M., Dong, Z., Sawada, O., Maeda, T., Maeda, A., & Palczewski, K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69076 · Cited by 79
Self-citationAgonists at the Serotonin Receptor (5-HT1A) Protect the Retina from Severe Photo-Oxidative Stress
Collier, R. J., Patel, Y., Martin, E. A., Dembinska, O., Hellberg, M., Krueger, D. S., Kapin, M. A., & Romano, C. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6304 · Cited by 78
Collier, R. J., Wang, Y., Smith, S. S., Martin, E., Ornberg, R., Rhoades, K., & Romano, C. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6418 · Cited by 78
Mikkonen, M., Soininen, H., & Pitk�nen, A. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971110)388:1<64::aid-cne5>3.0.co;2-m · Cited by 77
Visual Cycle Modulation as an Approach toward Preservation of Retinal Integrity
Bavik, C., Henry, S. H., Zhang, Y., Mitts, K., McGinn, T., Budzynski, E., Pashko, A., Lieu, K. L., Zhong, S., Blumberg, B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124940 · Cited by 75
Maeda, T., Van Hooser, J. P., Driessen, C. A. G. G., Filipek, S., Janssen, J. J. M., & Palczewski, K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01741.x · Cited by 75
Self-citationKubota, R., Al-Fayoumi, S., Mallikaarjun, S., Patil, S., Bavik, C., & Chandler, J. W. (2014) · Retina · doi:10.1097/01.iae.0000434565.80060.f8 · Cited by 73
Lenis, T. L., Sarfare, S., Jiang, Z., Lloyd, M. B., Bok, D., & Radu, R. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620299114 · Cited by 72
Vigabatrin, the GABA‐transaminase inhibitor, damages cone photoreceptors in rats
Duboc, A., Hanoteau, N., Simonutti, M., Rudolf, G., Nehlig, A., Sahel, J., & Picaud, S. A. (2004) · Annals of Neurology · doi:10.1002/ana.20081 · Cited by 71
Long-term effects of light damage on the retina of albino and pigmented rats.
Wasowicz, M. Y., Morice, C., Ferrari, P., Callebert, J., & Versaux‐Botteri, C. (2002) · PubMed · Cited by 70
Jaffe, G. J., Schmitz-Valckenberg, S., Boyer, D., Heier, J., Wolf-Schnurrbusch, U., Staurenghi, G., Schmidt-Erfurth, U., & Holz, F. G. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.08.024 · Cited by 68
Tsukatani, T., Higuchi, T., & Matsumoto, K. (2005) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.03.056 · Cited by 65
Dugel, P. U., Novack, R. L., Csaky, K. G., Richmond, P. P., Birch, D. G., & Kubota, R. (2015) · Retina · doi:10.1097/iae.0000000000000606 · Cited by 64
Jaiswal, M., Haelterman, N. A., Sandoval, H., Xiong, B., Donti, T., Kalsotra, A., Yamamoto, S., Cooper, T. A., Graham, B. H., & Bellen, H. J. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002197 · Cited by 62
Neurochemical development of the degenerating rat retina.
Fletcher, E. L., & Kalloniatis, M. (1997) · PubMed · Cited by 59
Kimura, A. K., Namekata, K., Guo, X., Noro, T., Harada, C., & Harada, T. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.11.005 · Cited by 57
New approaches and potential treatments for dry age-related macular degeneration
Damico, F. M., Gasparin, F., Scolari, M. R., Pedral, L. S., & Takahashi, B. S. (2012) · Arquivos Brasileiros de Oftalmologia · doi:10.1590/s0004-27492012000100016 · Cited by 54
Antiepileptic Drugs and Visual Function
Verrotti, A., Manco, R., Matricardi, S., Franzonı, E., & Chiarelli, F. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.03.001 · Cited by 52
Sun, D., Sahu, B., Gao, S., Schur, R. M., Vaidya, A. M., Maeda, A., Palczewski, K., & Lu, Z.-R. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.02.005 · Cited by 47
Self-citationTopiramate reduces excitotoxic and ischemic injury in the rat retina
Yoneda, S., Tanaka, E., Goto, W., Ota, T., & Hara, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02270-4 · Cited by 44
Natural Compounds from Saffron and Bear Bile Prevent Vision Loss and Retinal Degeneration
Fernández‐Sánchez, L., Lax, P., Noailles, A., Jeréz, A. A., Maneu, V., & Cuenca, N. (2015) · Molecules · doi:10.3390/molecules200813875 · Cited by 44
Wang, Q., Jammoul, F., Duboc, A., Gong, J., Manuel, S. M., Dubus, É., Craft, C. M., Wen, Y., Sahel, J., & Picaud, S. A. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06175.x · Cited by 41
Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics
Sparrow, J. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600474113 · Cited by 39
Atlasz, T., Szabadfi, K., Kiss, P., Babai, N. Z., Kőszegi, Z., Tamás, A., Reglődi, D., & Gabriel, R. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9059-5 · Cited by 37
Retinal Function Loss after Monocarboxylate Transport Inhibition
Bui, B. V., Kalloniatis, M., & Vingrys, A. J. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0695 · Cited by 36
Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.
Mitton, K. P., Guzman, A. E., Deshpande, M., Byrd, D., DeLooff, C., Mkoyan, K., Zlojutro, P. A., Wallace-Povirk, A., Metcalf, B., Laux, K., et al. (2014) · PubMed Central · Cited by 35
Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid
Bhalla, S., Joshi, D. D., Bhullar, S. S., Kasuga, D. T., Park, Y., & Kay, C. N. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303084 · Cited by 32
New retinal light damage QTL in mice with the light-sensitive RPE65 LEU variant
Danciger, M., Lyon, J., Worrill, D., Hoffman, S., Lem, J., Remé, C. E., Wenzel, A., & Grimm, C. (2004) · Mammalian Genome · doi:10.1007/s00335-003-2336-2 · Cited by 30
O'Byrne, C. P., Feehily, C., Ham, R., & Karatzas, K. A. G. (2010) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2010.10.017 · Cited by 30
Coyner, A. S., Ryals, R. C., Ku, C. A., Fischer, C. M., Patel, R. C., Datta, S., Yang, P. G., Wen, Y., Hen, R., & Pennesi, M. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159776 · Cited by 29
Sarpogrelate, a 5-HT 2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy
Tullis, B. E., Ryals, R. C., Coyner, A. S., Gale, M. J., Alex, N., Ku, C. A., Dain, R., Sinha, W., Shreya, D., Yuquan, W., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16378 · Cited by 28
Glial cells in the bird retina
Won, M. H., Kang, T., & Cho, S. S. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000715)50:2<89::aid-jemt1>3.0.co;2-9 · Cited by 28
PACAP Improves Functional Outcome in Excitotoxic Retinal Lesion: An Electroretinographic Study
Varga, B. R., Szabadfi, K., Kiss, P., Fábián, E., Tamás, A., Griecs, M., Gabriel, R., Reglődi, D., Kemény‐Beke, Á., Pámer, Z., et al. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9406-1 · Cited by 26
Zhang, J., Dong, Z., Mundla, S. R., Hu, X., Seibel, W. L., Papoian, R., Palczewski, K., & Golczak, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.096560 · Cited by 24
Self-citationSrivastava, P., Sinha-Mahapatra, S. K., Ghosh, A., Srivastava, I., & Dhingra, N. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123896 · Cited by 21
Neurotransmitter contents in the retina of RCS rat
Okada, M., Okuma, Y., Osumi, Y., Nishihara, M., Yokotani, K., & Ueno, H. (2000) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s004170000215 · Cited by 17
Manganese-Enhanced MRI for Preclinical Evaluation of Retinal Degeneration Treatments
Schur, R. M., Li, S., Sahu, B., Yu, G.-P., Gao, S., Yu, X., Maeda, A., Palczewski, K., & Lu, Z. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16522 · Cited by 14
Self-citationPhotoreceptor degeneration and loss of immunoreactive GABA in the Abyssinian cat retina
Ehinger, B., Narfström, K. L., Nilsson, S. E. G., & Veen, T. V. (1991) · Experimental Eye Research · doi:10.1016/0014-4835(91)90124-w · Cited by 13
Regulation of GABA content by glucose in the chick retina
Miya-Coreixas, V. S., Santos, R. M., Carpi-Santos, R., Gardino, P. F., & Calaza, K. D. C. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.07.026 · Cited by 10
Visual field defect during therapy with valproic‐acid
Tilz, C., Wang‐Tilz, Y., Jünemann, A., Stefan, H., & Michelson, G. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01524.x · Cited by 8
Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina
Pisani, F., Costa, C., Caccamo, D., Mazzon, E., Gorgone, G., Oteri, G., Calabresi, P., & Ientile, R. (2006) · Experimental Brain Research · doi:10.1007/s00221-005-0298-1 · Cited by 6
Vigabatrin can enhance electroretinographic responses in pigmented and albino rats
Akula, J. D., Noonan, E. R., Nardo, A. D., Favazza, T. L., Zhang, N., Şahin, M., Hansen, R. M., & Fulton, A. B. (2015) · Documenta Ophthalmologica · doi:10.1007/s10633-015-9491-0 · Cited by 5
Inactivation of GABA transaminase by 3-chloro-1-(4-hydroxyphenyl)propan-1-one
Tao, Y., Xu, H., & Yang, X. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.033 · Cited by 3
SanGiovanni, J. P., Rosen, R., & Kaushal, S. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666140811113606 · Cited by 3
Research works printed but not linked: 1
- 10.1002/(SICI)1096-9861(19971110)388:1<1::AID-CNE1>3.0.CO;2-5 · doi:10.1002/(sici)1096-9861(19971110)388:1<1::aid-cne1>3.0.co;2-5
Cited by
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
Rôżanowska, M. (2023) · Antioxidants · doi:10.3390/antiox12122111 · Cited by 66
Carullo, G., Federico, S., Relitti, N., Gemma, S., Butini, S., & Campiani, G. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00358 · Cited by 33
Telegina, D. V., Antonenko, A. K., Фурсова, А. Ж., & Kolosova, N. G. (2022) · Biogerontology · doi:10.1007/s10522-022-09983-w · Cited by 23
“Nowadays, there is some information about deviations in neurotransmitter systems in the retina in AMD (George et al. 2018; Schur et al. 2018).”
BackgroundBoff, J. M., Shrestha, A. P., Madireddy, S., Viswaprakash, N., Santina, L. D., & Vaithianathan, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042226 · Cited by 20
“Recent investigations involve the use of chloride derivatives as alternative therapeutics that maximize positive outcomes while minimizing irreversible side effects, thereby bypassing retinal risks [234].”
Background
Metadata
- Authors
- Schur, R. M., Gao, S., Yu, G., Chen, Y., Maeda, A., Palczewski, K., & Lu, Z.-R.
- Affiliations
- Case Western Reserve University (US)
- Case Center for Biomolecular Engineering Department of Biomedical Engineering School of Engineering, Case Western Reserve University Cleveland Ohio USA
- Corresponding author
- Lu, Zheng-Rong
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2018-01-24
- Volume
- 32
- Issue
- 6
- Pages
- 3289-3300
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC5956245
- OpenAlex
- W2784969173
- Cited by
- 19
- References
- 75
- Citations by year
- 2025: 2 · 2024: 8 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY027283, EY024864)
- National Institute of Biomedical Imaging and Bioengineering (T32EB007509)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
- Keywords
- photoreceptor degeneration, light-induced retinal degeneration, tiagabine, vigabatrin, antiepileptic drugs, ABCA4, neuroprotection, inhibitory neurotransmission, prophylaxis, visual function
- MeSH terms
- Alcohol Oxidoreductases, Animals, gamma-Aminobutyric Acid, Light, Propiophenones, Retinal Degeneration, Mice, Knockout, ATP-Binding Cassette Transporters, Photoreceptor Cells, Vertebrate, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.